Search Results - "Gómez, Remedios"

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP) by Manzanedo, Israel, Pereira, Fernando, Rihuete Caro, Cristina, Pérez-Viejo, Estíbalitz, Serrano, Ángel, Gutiérrez Calvo, Alberto, Regueira, Fernando M., Casado-Adam, Ángela, Cascales-Campos, Pedro A., Arteaga, Xabier, García-Fadrique, Alfonso, Gómez Sanz, Remedios, López García, Adela, Zozaya, Gabriel, Arjona, Álvaro, Gil Martínez, José

“…Background Gastric cancer (GC) with peritoneal carcinomatosis (PC) is traditionally considered a terminal stage of the disease. The use of a multimodal…”
Get full text

HLA-G 3'UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients by Vaquero-Yuste, Christian, Juarez, Ignacio, Molina-Alejandre, Marta, Molanes-López, Elisa María, López-Nares, Adrián, Suárez-Trujillo, Fabio, Gutiérrez-Calvo, Alberto, López-García, Adela, Lasa, Inmaculada, Gómez, Remedios, Fernández-Cruz, Eduardo, Rodrígez-Sainz, Carmen, Arnaiz-Villena, Antonio, Martín-Villa, José Manuel

“…HLA-G is a non-classical class I HLA molecule that induces tolerance by acting on receptors of both innate and adaptive immune cells. When overexpressed in…”
Get full text

Multiple erythrophagocytosis by erythroid blasts in acute myeloid leukemia with BCR-ABL1 by Mellado-Gázquez, África, Gómez-Núñez, M. Remedios, Jurado-Herrera, Sergio, Prats-Martín, Concepción, Caballero-Velázquez, Teresa, Morales-Camacho, Rosario M.

Get full text

TGFB1 polymorphisms and TGF‐β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease by Juarez, Ignacio, Gutierrez, Alberto, Vaquero‐Yuste, Christian, Molanes‐López, Elisa M., López, Adela, Lasa, Inmaculada, Gómez, Remedios, Martin‐Villa, José Manuel

“…TGF‐β1 is involved in tumour growth. Four TGFB1 SNPs and TGF‐β1 production by stimulated PBMC were determined in seventy‐eight gastric adenocarcinoma patients…”
Get full text

Defects at the Posttranscriptional Level Account for the Low TCRζ Chain Expression Detected in Gastric Cancer Independently of Caspase-3 Activity by Martin-Villa, José M., Lopez, Adela, Rodríguez-Pérez, Noelia, Gutiérrez-Calvo, Alberto, Juárez, Ignacio, Castro-Sánchez, Patricia, Aguinaga-Barrilero, Ana, Gómez, Remedios

“…Background. Reduced TCRζ chain surface has been reported in T cells from patients with different inflammatory conditions and cancer. However, the causes of…”
Get full text

Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma by Díez-Alonso, Manuel, Mendoza-Moreno, Fernando, Gómez-Sanz, Remedios, Matías-García, Belén, Ovejero-Merino, Enrique, Molina, Raquel, Soto-Schütte, Sonia, San Juan, Alberto, Gutierrez-Calvo, Alberto

“…Objective. The main objective of the study was to determine the effect of the presence of mutation in the KRAS gene on the survival in patients with colorectal…”
Get full text

The Immune Modulation HLA-G01:01:01 Full Allele Is Associated with Gastric Adenocarcinoma Development by Suarez-Trujillo, Fabio, Juarez, Ignacio, Vaquero-Yuste, Christian, Gutierrez-Calvo, Alberto, Lopez-García, Adela, Lasa, Inmaculada, Gomez, Remedios, Martin-Villa, José Manuel, Arnaiz-Villena, Antonio

“…The Human Leukocyte Antigen (HLA) system contains a set of genes involved at many levels in the innate and adaptive immune response. Among the non-classical…”
Get full text

Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy by Pintado, Maria Consuelo, Lasa Unzúe, Inmaculada, Gómez Sanz, Remedios, Diez Alonso, Manuel, Ortega, Miguel A, Álvarez de Mon, Melchor, Nevado Losada, Emilio, Gutierrez Calvo, Alberto

“…Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have benefits for survival in some cancers with peritoneal metastasis…”
Get full text

Side-Effects on the Renal function of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy by Beltrán, Diego, Pintado, María-Consuelo, Oñoro, Ana, Unzúe, Inmaculada Lasa, Sanz, Remedios Gómez, Alonso, Manuel Diez, Ortega, Miguel A, de Mon, Melchor Álvarez, Losada, Emilio Nevado, Calvo, Alberto Gutierrez

“…Acute kidney injury (AKI) is a frequent complication in patients undergo-ing cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)…”
Get full text

210 Development of mixed strategy to implement Kids Save Lives at school through the figure of the School Nurse by Gómez, Juan Manuel Lucas, Oliver, Ana Fátima Navarro, Martínez, Juan Carlos Latorre, Sánche, Remedios Gómez, Caravaca, Sonia Sanchez, Rubio, Ana García, Ríos, Manuel Pardo

Get full text

A Reliable and Standardizable Differential PCR and qPCR Methodology Assesses HER2 Gene Amplification in Gastric Cancer by Juarez, Ignacio, Toro-Fernandez, Juan Francisco, Vaquero-Yuste, Christian, Molina-Alejandre, Marta, Lasa, Inmaculada, Gomez, Remedios, Lopez, Adela, Martin-Villa, Jose Manuel, Gutierrez, Alberto

“…We have applied two PCR techniques, differential PCR (diffPCR) and qPCR for the identification of HER2 gene amplifications in genomic DNA of tumor and distal…”
Get full text

296 Regional CPR Education Program in Murcia Schools by Gómez, Juan Manuel Lucas, Oliver, Ana Fátima Navarro, Martínez, uan Carlos Latorre, Sánchez, Remedios Gómez, Caravaca, Sonia Sanchez, Rubio, Ana García, Gil, Francisco Celdrán, Adán, Lázaro Campuzano, Rios, Manuel Pardo

Get full text

HLA-G high-expressor 3’UTR markers are linked to gastric cancer development and survival by Vaquero-Yuste, Christian, Juarez, Ignacio, Molina-Alejandre, Marta, Molanes-López, Elisa María, Gutiérrez-Calvo, Alberto, López-García, Adela, Lasa, Inmaculada, Gómez, Remedios, Arnaiz-Villena, Antonio, Martín-Villa, Jose Manuel

“…Gastric cancer ranks fifth in both world prevalence and lethality, with a 5-year survival of less than 30%. HLA-G, a non-classical class I HLA gene, has…”
Get full text

Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer by Aguinaga-Barrilero, Ana, Juarez, Ignacio, Vaquero-Yuste, Christian, Molina-Alejandre, Marta, Gutiérrez-Calvo, Alberto, Lasa, Inmaculada, López, Adela, Gómez, Remedios, Molanes-López, Elisa M., Martin-Villa, José M.

“…•Regulatory cells limit immune responses to tumors.•Regulatory FoxP3ー, TGFβ-producing, LAP-expressing cells have been recently described.•These cells are…”
Get full text

Crònica de les Segundas Jornadas de Español para Fines Específicos de Viena by Veiga Gómez, Remedios

Get full text

Has Lymphadenectomy Extension (D1 Vs D2) an Impact in Survival in Patients with Positive Nodes after Surgery (Pn+)? by Merino, Enrique Ovejero, López García, Adela Petra, Moreno, Fernando Mendoza, Hernández, Ruth Marcos, Fernández, José Martín, Unzúe, Inmaculada Lasa, Sanz, María de los Remedios Gómez, Furtado Duarte Lobo Gonçalves, Isabel María, García, Belén Matías, Schütte, Sonia Soto, Gutiérrez Calvo, Alberto José

Get full text

Are There Differences in Survival Between Total and Subtotal Gastrectomy In B-Curability Patients (JRSGC) with Other Than T1 Tumours? by Merino, Enrique Ovejero, López García, Adela Petra, Moreno, Fernando Mendoza, Fernández, José Martín, Unzúe, Inmaculada Lasa, Sanz, María de los Remedios Gómez, Hernández, Ruth Marcos, Furtado Duarte Lobo Gonçalves, Isabel María, García, Belén Matías, Schütte, Sonia Soto, Gutiérrez Calvo, Alberto José

Get full text

Does JRSGC "Curability Classification" of Gastric Cancer Impact Survival in Our Population or TNM Alone is Really Enough? by Merino, Enrique Ovejero, López García, Adela Petra, Moreno, Fernando Mendoza, Sanz, María de los Remedios Gómez, Hernández, Ruth Marcos, Fernández, José Martín, Inmaculada, Lasa Unzúe, Furtado Duarte Lobo Gonçalves, Isabel María, García, Belén Matías, Schütte, Sonia Soto, Gutiérrez Calvo, Alberto José

Get full text

Are There Differences in Survival Between Total and Subtotal Gastrectomy in A-Curability Patients (JRSGC) with Other Than T1 Tumours? by Merino, Enrique Ovejero, López García, Adela Petra, Moreno, Fernando Mendoza, Hernández, Ruth Marcos, Fernández, José Martín, Unzúe, Inmaculada Lasa, Sanz, María de los Remedios Gómez, Furtado Duarte Lobo Gonçalves, Isabel María, García, Belén Matías, Schütte, Sonia Soto, Gutiérrez Calvo, Alberto José

Get full text

Intuitive Information for Patients: How to Answer the Question, "How Many Time Do I Have Left with My Gastric Cancer?". Survival by Ptnm: Global (Months-Years), 5 years %, 10 years by Merino, Enrique Ovejero, López García, Adela Petra, Moreno, Fernando Mendoza, Unzúe, Inmaculada Lasa, Sanz, María de los Remedios Gómez, Hernández, Ruth Marcos, Fernández, José Martín, Furtado Duarte Lobo Gonçalves, Isabel María, García, Belén Matías, Schütte, Sonia Soto, Gutiérrez Calvo, Alberto José

Get full text